首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1584092

心包膜穿刺術市場，按適應症、按疾病類型、按最終用戶、按國家和地區 - 2024-2032年產業分析、市場規模、市場佔有率和預測

Pericardiocentesis Procedures Market, By Indication, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年10月26日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年心包膜穿刺術市場規模為 1.8109億美元，2024年至2032年年複合成長率為 3.29%。

心包膜穿刺術市場-市場動態

心血管疾病盛行率不斷上升，癌症治療方法不斷增加，早期診斷預計將推動市場需求

心包膜炎、心臟衰竭和心包膜積液等心血管疾病的發生率不斷上升，增加了對心包膜穿刺術作為治療選擇的需求，促進了市場成長。心臟壓迫需要緊急心包穿刺術來緩解。超音波和超音波心動圖等影像技術的改進使心包穿刺術更加準確和安全，提高了採用率。這些影像工具對於指導手術過程非常重要。

對心包積液及其併發症的更多認知有助於更早發現和介入。再加上診斷能力的提高，推動了對心包膜穿刺術等手術的需求。某些癌症治療，例如化療和放療，可能會導致心包膜積水的副作用。這導致癌症患者，尤其是晚期疾病患者對心包膜穿刺術的需求增加。心包膜穿刺術導管療法的技術進步，包括針頭設計、導管技術和引流系統的改進，使手術更加高效、安全，促進了其採用並支持市場成長。

心包膜穿刺術市場 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032年）每年將以 3.29%左右的年複合成長率成長

根據適應症細分，由於癌症的高盛行率，預計惡性腫瘤細分市場將在2023年顯示最大的市場佔有率。

根據疾病類型細分，由於心臟病的增加，肺癌細分市場成為2023年主要的疾病類型細分市場。

根據最終用戶細分，由於需要診斷晚期癌症、結核病等，醫院和診所細分市場是2023年領先的最終用戶細分市場。

依地區分類，由於心血管疾病的高發生率，北美將成為2023年的主要收入來源。

心包膜穿刺術市場細分分析：

全球心包膜穿刺術市場根據適應症、疾病類型、最終用戶和地區進行細分。

市場依適應症分為五類：感染、惡性腫瘤、心臟、發炎等。惡性腫瘤細分市場佔據主導地位。轉移性腫瘤發生率的增加主要是促進了細分市場的成長。

市場依疾病類型分為四類：肺癌、乳癌、淋巴瘤等。肺癌細分市場佔據主導地位。心臟驟停和肺部疾病發生率的增加促進市場需求。

根據最終用戶，市場分為三類：醫院和診所、心臟中心等。醫院和診所領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。狼瘡、類風濕性關節炎和硬皮症等慢性免疫疾病的流行推動該細分市場的成長。

心包膜穿刺術市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。在北美，美國和加拿大是主要貢獻者，其中美國在程序數量和創新方面處於領先地位。受人口老化和心血管疾病發病率上升的推動，歐洲是另一個重要市場。在亞太地區，人們對心包膜積水和心臟病的認知和早期診斷不斷提高。中國、日本和印度是該地區的主要市場，導致心包穿刺術的需求不斷成長。

心包膜穿刺術市場-競爭格局：

心包膜穿刺術市場競爭激烈，主要參與者包括MedtronicBoston Scientific、BD 和Cook Medical，這些公司致力於技術創新和產品開發。公司根據醫療保健提供者和患者群體的具體需求提供客製化的心包穿刺套件，以確保該過程盡可能有效和高效。該公司開發下一代導管和引流系統，以提高心包膜穿刺術的安全性、精確度和舒適度。

2022年，Teleflex Incorporated推出了專門的導管和針頭系統，用於從心包腔排出液體。

2022年，Cook Medical宣布推出多種診斷和介入設備，包括心包穿刺套件和配件。

介紹
- 依地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美心包穿刺術主要製造商
- 北美市場規模和預測（依國家）
- 北美市場規模和預測（依適應症）
- 北美市場規模和預測（依疾病類型）
- 北美市場規模和預測（依最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲心包穿刺術主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模與預測（依適應症）
- 歐洲市場規模與預測（依疾病類型）
- 歐洲市場規模和預測（依最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區（APAC）
- 概述
- 亞太地區心包膜穿刺術主要製造商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依適應症）
- 亞太地區市場規模與預測（依疾病類型）
- 亞太地區市場規模和預測（依最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲心包膜穿刺術主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模與預測（依適應症）
- 拉丁美洲市場規模與預測（依疾病類型）
- 拉丁美洲市場規模和預測（依最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲心包膜穿刺術主要製造商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（依適應症）
- 中東和非洲市場規模及預測（依疾病類型）
- 中東和非洲市場規模及預測（依最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA其他地區

第11章主要供應商分析 - 心包膜穿刺術產業

競爭儀表板
公司簡介
- Boston Scientific Corporation
- Abbott Laboratories
- B. Braun Melsungen AG
- Cook Medical Inc.
- CR Bard Inc.
- Merit Medical Systems Inc.
- Teleflex Incorporated
- Cardinal Health Inc.
- Johnson & Johnson Services Inc.
- AngioDynamics Inc.
- Medtronic
- Smith's Medical
- BD
- Edwards Lifesciences
- Stryker Corporation
- Others

第12章 360 度分析師視角

第13章附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4082

REPORT HIGHLIGHT

Pericardiocentesis Procedures Market size was valued at USD 181.09 Million in 2023, expanding at a CAGR of 3.29% from 2024 to 2032.

Pericardiocentesis is a medical procedure used to remove excess fluid from the pericardium, the sac-like structure surrounding the heart. This fluid buildup, known as pericardial effusion, can put pressure on the heart, affecting its ability to function properly. In severe cases, it can lead to cardiac tamponade, a life-threatening condition where the heart cannot pump effectively due to the pressure.

Pericardiocentesis Procedures Market- Market Dynamics

Growing prevalence of cardiovascular disorders and rise in cancer therapies, early diagnosis is expected to propel market demand

The rising incidence of cardiovascular conditions such as pericarditis, heart failure, and pericardial effusion increases the demand for pericardiocentesis as a treatment option, which in turn is boosting market growth. Cardiac tamponade requires urgent pericardiocentesis for relief. Improved imaging technologies like ultrasound and echocardiography have made pericardiocentesis more accurate and safer, contributing to higher adoption rates. These imaging tools are essential for guiding the procedure.

Greater awareness of pericardial effusion and its complications has led to earlier detection and intervention. This, coupled with improved diagnostic capabilities, has driven the demand for procedures like pericardiocentesis. Certain cancer treatments, such as chemotherapy and radiation, can cause pericardial effusion as a side effect. This has led to increased demand for pericardiocentesis in cancer patients, especially those with advanced disease. Technological advancements in catheter-based therapies for pericardiocentesis, including improvements in needle design, catheter technology, and drainage systems, make the procedure more efficient and safer, boosting its adoption and supporting market growth.

Pericardiocentesis Procedures Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.29% over the forecast period (2024-2032)

Based on Indication segmentation, the malignancies segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of cancer.

Based on Disease Type segmentation, the lung cancer segment was the leading Disease Type segment in 2023, due to the rise in cardiac disorders.

Based on End User segmentation, the hospital & clinics segment was the leading End User segment in 2023, due to the need for diagnosis of advanced cancer, tuberculosis, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the high prevalence of cardiovascular diseases.

Pericardiocentesis Procedures Market- Segmentation Analysis:

Global Pericardiocentesis Procedures Market is segmented on the basis of Indication, Disease Type, End User, and Region.

The market is divided into five categories based on Indication: infections, malignancies, cardiac, inflammatory, and others. The malignancies segment dominates the market. Increasing incidence of metastatic tumors is mainly boosting segment growth.

The market is divided into four categories based on Disease Type: lung cancer, breast cancer, lymphoma, and others. The lung cancer segment dominates the market. The increasing incidence of cardiac arrests and lung diseases are fostering market demand.

The market is divided into three categories based on End User: hospital & clinics, cardiac centers, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The prevalence of chronic immune diseases like lupus, rheumatoid arthritis, and scleroderma, etc. are fueling segment growth.

Pericardiocentesis Procedures Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the United States and Canada are major contributors, with the U.S. leading in terms of procedural volume and innovation. Europe is another significant market, driven by the aging population and rising incidence of cardiovascular diseases. In Asia Pacific, rising awareness and early diagnosis of pericardial effusion and cardiac diseases. China, Japan, and India are the key markets in this region, contributing to the growing demand for pericardiocentesis procedures.

Pericardiocentesis Procedures Market- Competitive Landscape:

The Pericardiocentesis Procedures Market is highly competitive, driven by key players like Medtronic, Boston Scientific, BD, and Cook Medical, who focus on technological innovation and product developments. Companies are offering customized pericardiocentesis kits tailored to the specific needs of healthcare providers and patient populations, ensuring that the procedure is as effective and efficient as possible. Companies are developing next-generation catheters and drainage systems that improve the safety, precision, and comfort of pericardiocentesis procedures.

In 2022, Teleflex Incorporated introduced specialized catheters and needle systems for draining fluid from the pericardial space.

In 2022, Cook Medical announced the launch of a variety of diagnostic and interventional devices, including pericardiocentesis kits and accessories.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET KEY PLAYERS

Boston Scientific Corporation
Abbott Laboratories
B. Braun Melsungen AG
Cook Medical Inc.
CR Bard Inc.
Merit Medical Systems Inc.
Teleflex Incorporated
Cardinal Health Inc.
Johnson & Johnson Services Inc.
AngioDynamics Inc.
Medtronic
Smith's Medical
BD
Edwards Lifesciences
Stryker Corporation
Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

Infections
Malignancies
Cardiac
Inflammatory
Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

Lung cancer
Breast cancer
Lymphoma
Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospital & clinics
Cardiac centers
Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Pericardiocentesis Procedures Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Pericardiocentesis Procedures Market Snippet by Indication
- 2.1.2. Pericardiocentesis Procedures Market Snippet by Disease Type
- 2.1.3. Pericardiocentesis Procedures Market Snippet by End User
- 2.1.4. Pericardiocentesis Procedures Market Snippet by Country
- 2.1.5. Pericardiocentesis Procedures Market Snippet by Region
2.2. Competitive Insights

3. Pericardiocentesis Procedures Key Market Trends

3.1. Pericardiocentesis Procedures Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Pericardiocentesis Procedures Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Pericardiocentesis Procedures Market Opportunities
3.4. Pericardiocentesis Procedures Market Future Trends

4. Pericardiocentesis Procedures Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Pericardiocentesis Procedures Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Pericardiocentesis Procedures Market Landscape

6.1. Pericardiocentesis Procedures Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Pericardiocentesis Procedures Market - By Indication

7.1. Overview
- 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 7.1.2. Infections
- 7.1.3. Malignancies
- 7.1.4. Cardiac
- 7.1.5. Inflammatory
- 7.1.6. Others

8. Pericardiocentesis Procedures Market - By Disease Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 8.1.2. Lung cancer
- 8.1.3. Breast cancer
- 8.1.4. Lymphoma
- 8.1.5. Others

9. Pericardiocentesis Procedures Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospital & clinics
- 9.1.3. Cardiac centers
- 9.1.4. Others

10. Pericardiocentesis Procedures Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Pericardiocentesis Procedures Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pericardiocentesis Procedures Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pericardiocentesis Procedures Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pericardiocentesis Procedures Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pericardiocentesis Procedures Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pericardiocentesis Procedures Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Boston Scientific Corporation
- 11.2.2. Abbott Laboratories
- 11.2.3. B. Braun Melsungen AG
- 11.2.4. Cook Medical Inc.
- 11.2.5. CR Bard Inc.
- 11.2.6. Merit Medical Systems Inc.
- 11.2.7. Teleflex Incorporated
- 11.2.8. Cardinal Health Inc.
- 11.2.9. Johnson & Johnson Services Inc.
- 11.2.10. AngioDynamics Inc.
- 11.2.11. Medtronic
- 11.2.12. Smith's Medical
- 11.2.13. BD
- 11.2.14. Edwards Lifesciences
- 11.2.15. Stryker Corporation
- 11.2.16. Others